Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T04:18:29.258Z Has data issue: false hasContentIssue false

Enhanced Human Bone Marrow Mesenchymal Stem Cell Chondrogenic Differentiation on Cold Atmospheric Plasma Modified Cartilage Scaffold

Published online by Cambridge University Press:  19 December 2014

Wei Zhu
Affiliation:
Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC, United States
Michael Keidar
Affiliation:
Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC, United States
Lijie Grace Zhang
Affiliation:
Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC, United StatesDepartment of Medicine, The George Washington University, Washington, DC, United States
Get access

Abstract

Articular cartilage is prone to degeneration and possesses extremely poor self-healing capacity due to its low cell density and absence of blood vessels. It has extensively reported tissue engineered scaffold can be a promising approach for cartilage repair. However, there still remains an inherent lack of desirable scaffolds that stimulate cartilage regrowth with appropriate functional properties. Therefore, in this study, we develop a biomimetic cartilage substitute comprising of electrospun polycaprolactone (PCL) with cold atmospheric plasma (CAP) modified cell favorable surface and sustained bioactive factor (bovine serum albumin (BSA) or transforming growth factor beta 1 (TGF-β1)) incorporated microspheres inside for improving stem cell chondrogenesis and cartilage regeneration. Scanning electron microscopy (SEM) analysis showed the drug delivery spheres homogeneously distribution in the fibrous scaffold. Furthermore, CAP treatment renders the scaffold’s surface more hydrophilic and results in more specific vitronectin adsorption as illustrated by contact angle and ELISA testing. Our results showed that the CAP treated scaffold can greatly improve growth and chondrogenic differentiation (such as increased glycosaminoglycan (GAG) synthesis) of human bone marrow-derived mesenchymal stem cells (MSCs).

Information

Type
Articles
Copyright
Copyright © Materials Research Society 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable